APA Zitierstil

Pipas, J. M., Zaki, B. I., McGowan, M. M., Tsapakos, M. J., Ripple, G. H., Suriawinata, A. A., . . . Barth, R. J. (2012). Neoadjuvant cetuximab, twice-weekly gemcitabine, and intensity-modulated radiotherapy (IMRT) in patients with pancreatic adenocarcinoma. Oxford University Press.

Chicago Zitierstil

Pipas, J. M., et al. Neoadjuvant Cetuximab, Twice-weekly Gemcitabine, and Intensity-modulated Radiotherapy (IMRT) in Patients With Pancreatic Adenocarcinoma. Oxford University Press, 2012.

MLA Zitierstil

Pipas, J. M., et al. Neoadjuvant Cetuximab, Twice-weekly Gemcitabine, and Intensity-modulated Radiotherapy (IMRT) in Patients With Pancreatic Adenocarcinoma. Oxford University Press, 2012.

Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.